Dimensional Fund Advisors
VNDA icon

Dimensional Fund Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$12.2M Buy
2,585,757
+46,082
+2% +$218K ﹤0.01% 2203
2025
Q1
$11.7M Buy
2,539,675
+51,156
+2% +$235K ﹤0.01% 2184
2024
Q4
$11.9M Buy
2,488,519
+227,428
+10% +$1.09M ﹤0.01% 2236
2024
Q3
$10.6M Buy
2,261,091
+247,284
+12% +$1.16M ﹤0.01% 2282
2024
Q2
$11.4M Buy
2,013,807
+292,172
+17% +$1.65M ﹤0.01% 2208
2024
Q1
$7.08M Sell
1,721,635
-246,350
-13% -$1.01M ﹤0.01% 2453
2023
Q4
$8.31M Sell
1,967,985
-196,573
-9% -$830K ﹤0.01% 2393
2023
Q3
$9.35M Buy
2,164,558
+215,175
+11% +$930K ﹤0.01% 2293
2023
Q2
$12.8M Sell
1,949,383
-834,307
-30% -$5.5M ﹤0.01% 2142
2023
Q1
$18.9M Sell
2,783,690
-70,142
-2% -$476K 0.01% 1932
2022
Q4
$21.1K Buy
2,853,832
+118,856
+4% +$878 0.01% 1847
2022
Q3
$27M Buy
2,734,976
+54,951
+2% +$543K 0.01% 1648
2022
Q2
$29.2M Buy
2,680,025
+416,866
+18% +$4.54M 0.01% 1653
2022
Q1
$25.6M Buy
2,263,159
+229,581
+11% +$2.6M 0.01% 1839
2021
Q4
$31.9M Buy
2,033,578
+103,696
+5% +$1.63M 0.01% 1725
2021
Q3
$33.1M Sell
1,929,882
-36,545
-2% -$626K 0.01% 1720
2021
Q2
$42.3M Buy
1,966,427
+238,066
+14% +$5.12M 0.01% 1572
2021
Q1
$26M Buy
1,728,361
+176,123
+11% +$2.65M 0.01% 1903
2020
Q4
$20.4M Buy
1,552,238
+84,573
+6% +$1.11M 0.01% 1977
2020
Q3
$14.2M Buy
1,467,665
+34,657
+2% +$335K 0.01% 2034
2020
Q2
$16.4M Buy
1,433,008
+97,663
+7% +$1.12M 0.01% 1966
2020
Q1
$13.8M Buy
1,335,345
+137,624
+11% +$1.43M 0.01% 1952
2019
Q4
$19.7M Buy
1,197,721
+76,805
+7% +$1.26M 0.01% 2053
2019
Q3
$14.9M Buy
1,120,916
+153,512
+16% +$2.04M 0.01% 2164
2019
Q2
$13.6M Buy
967,404
+182,786
+23% +$2.58M 0.01% 2258
2019
Q1
$14.4M Buy
784,618
+253,913
+48% +$4.67M 0.01% 2228
2018
Q4
$13.9M Buy
530,705
+270,795
+104% +$7.08M 0.01% 2186
2018
Q3
$5.97M Buy
+259,910
New +$5.97M ﹤0.01% 2627
2016
Q3
Sell
-25,128
Closed -$281K 3284
2016
Q2
$281K Hold
25,128
﹤0.01% 3131
2016
Q1
$210K Buy
25,128
+2,000
+9% +$16.7K ﹤0.01% 3174
2015
Q4
$215K Buy
23,128
+1,900
+9% +$17.7K ﹤0.01% 3207
2015
Q3
$239K Buy
21,228
+3,300
+18% +$37.2K ﹤0.01% 3222
2015
Q2
$228K Buy
+17,928
New +$228K ﹤0.01% 3232